



NOVEL ORAL DELIVERY OF IBUPROFEN SOLUTION IN HARD GELATIN CAPSULES 
Original Article 
 
FORUM JANAK JALUNDHWALA1*, VAISHALI LONDHE1, JNANADEVA BHAT2, SURYA SINGH2 
1Shobhaben Pratapbhai Patel School of Pharmacy and Technology Management, SVKM's NMIMS, Mumbai, India, 2
Received: 04 Mar 2019 Revised and Accepted: 23 Apr 2019 
Formulation 
Development Department, ACG Associated Capsules Pvt. Ltd., Mumbai, India 
Email: forum.jalundhwala@gmail.com 
ABSTRACT 
Objective: The primary objective of the project was to formulate and evaluate hard capsule containing the solution of ibuprofen. It also included 
enhancement of solubility of ibuprofen in hydrophilic solvents to obtain a unit dose capsule acceptable for human consumption. 
Methods: Solution of ibuprofen was developed by the salt formation of partial drug using potassium hydroxide in PEG 600 and water. The solution 
was encapsulated in hard capsules with band sealing. The final formulation was evaluated for uniformity of weight, disintegration, drug content and 
stability. The dissolution profile was compared with that of available marketed tablets and softgels. 
Results: The capsules were evaluated and found compliant as per specifications mentioned in general monograph of capsules in IP 2014. The 
uniformity of weight of the batch of capsules was found to be 734.8 mg (±0.58). The disintegration time of these capsules was observed to be 4.45 
min. The drug content was found to be 100.03% and the product is stable over three months of test period under room temperature as well as 
accelerated conditions. The dissolution profile showed that softgels take longer time to release the drug whereas marketed tablets showed a 
dissolution profile comparable with that of formulated capsules. 
Conclusion: The developed capsule is a unit dose of liquid containing solubilized ibuprofen delivering the drug directly into the gastrointestinal 
tract (GIT). These are newer solid oral dosage forms with higher patient compliance and ease in manufacturing. They require lesser steps and 
manufacturing area when compared to the manufacturing of compressed tablets. 
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Ibuprofen is a commonly prescribed non-steroidal anti-
inflammatory drug (NSAID) [1, 2]. It is also widely prescribed for its 
analgesic properties [3]. The drug is used for the treatment of 
postoperative, epidural, dysmenorrheal and dental pain in addition 
to migraine, rheumatoid arthritis and other musculoskeletal 
disorders [4]. The management of acute pain is satisfactorily 
achieved on quick absorption of the drug into the bloodstream [5]. 
The absorption of drug increases when administered directly in the 
solubilized form [6]. Ibuprofen is also reported to cause gastric 
disturbances when administered orally [7, 8]. To minimize this 
gastric irritation, ibuprofen should be absorbed from the 
gastrointestinal tract (GIT) as quickly as possible [9]. The solid oral 
dosage forms are one of the most patient compliant routes of 
administration. Formulation scientists are working on different 
methods to decrease the gastric disturbances due to the 
administration of solid oral dosage forms of ibuprofen. Various 
researches have tried different formulations like Self Emulsifying 
Drug delivery systems (SEDDS), Self micro emulsifying drug delivery 
systems (SMEDDS)
As a result, lot of latest research includes encapsulation of solubilized 
liquids containing ibuprofen in softgels. Soft gels are dosage forms 
manufactured in situ. The shells are made up of gelatine and plasticizer. 
The liquid to be encapsulated can be a solution, emulsion or a 
suspension [24]. Softgels require dedicated machines for manufacturing 
and also poses a large ratio of rejection or quality hurdles during 
manufacturing. Softgels are also not a very stable dosage form. 
, solid dispersion, Complexation, co-
crystallization and other techniques with aim of increasing 
bioavailability of ibuprofen when administered orally [10-21]. Many 
researchers overcome gastric irritation by the use of a targeted drug 
delivery system. Amongst solid oral dosage forms, coated tablets are 
most commonly marketed dosage form of ibuprofen [22]. Coated 
tablets are compressed blend of drug and excipients with a film 
coating. This process involves many steps and evaluation of many 
in-process quality control parameters. They also require a large 
manufacturing area. Any changes in particle size, compression 
pressure can directly lead to variation in the quality of manufactured 
tablets [23]. These tablets also are slow in absorption when 
compared to administration of solubilized ibuprofen.  
Novel approach to overcome these hurdles is to encapsulate 
solubilized drug into two-piece hard gelatine capsules [25]. The two-
piece capsules are available in a variety of material, sizes and 
shapes. The design of these shells is modified for them to efficiently 
encapsulate a liquid [26]. They are prefabricated and the liquid fill 
material is filled. They are then band sealed to avoid any leakage 
[27]. Such a manufacturing process requires fewer steps and lesser 
area for large scale production [28, 29].  
The objective of the study was to formulate and evaluate hard 
gelatin capsules with ibuprofen solution. It also included a 
comparative study of the dissolution profile of the formulated hard 
capsule with marketed softgels and coated tablets. 
MATERIALS AND METHODS 
Chemicals and reagents 
Ibuprofen was procured from BASF company (Batch no.: IB1V1517), 
polyethlene glycol (PEG) 600 from Merck specialities Pvt. Ltd. (Batch 
No.: SF2S620076) and potassium hydroxide pellets of analytical 
grade Rankem (Batch No.: P005D05) were procured. Hard gelatine 
capsules of size 1 (Batch No 1100134276) were provided by ACG 
Associated Capsules Pvt. Ltd. The de-mineralized (D. M.) water used 
was prepared in-house. Marketed OTC products of Tablet Brufen®, 
manufactured by Abbott Pvt. Ltd. (batch No. B2867459) and Advil®
Compatibility studies 
, 
manufactured by Pfizer (batch no. R13920) were purchased. 
Gelatine capsule shells are moisture sensitive. Compatibility studies 
were conducted between gelatine shells and various solvents including 
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water, soya oil, cremophor EL, polysorbate 80, triacetin, propylene 
glycol, glycerine, PEG 400, PEG 600, Transcutol P, Transcutol P 20% and 
Transcutol P 40%. 10 gelatine capsules of size ‘00' were filled upto 80% 
with the solvent under test. It was then band sealed using capsule sealing 
machine (LBS-023 by ACG Pam Pharmaceutical and Allied Machinery 
Company Pvt. Ltd.) and stored for observation for 7 d. Visual inspection 
for any cracks or softening of the shell was noted. 
Solubility studies 
To study the solubility of ibuprofen, certain solvents were 
shortlisted from the results of compatibility studies. To test the 
solubility of drug in individual solvents, 25 ml of each solvent was 
saturated with the drug. The flasks were subjected to rotary shaking 
using a shaker for 24 h at room temperature. The solution was then 
filtered using whatmann filter paper and diluted with water to 
obtain absorbance. Absorbance was measured using UV-Visible 
spectrophotometer (Thermo Scientific Evolution 201) at 221 nm. 
Formulation trials 
Depending on the results obtained from solubility and compatibility 
various formulation trials were conducted as shown in table 1. Trials 
were designed to achieve the target fill weight of 700-900 mg for a 
size ‘00' capsule. The drug was dissolved in warm PEG 600. To this, 
an ionizing agent in the form of potassium hydroxide pellets was 
added [30, 31]. It was stirred till homogenous and filled in 10 
gelatine capsules of size ‘00'. It was band sealed and kept under 
observation. Visual inspection was conducted for any changes in the 
appearance of gelatine shell.
  
Table 1: Content (mg/capsule) of ingredients in each formulation trial 
Batch No. 0001 0002 0003 0004 0005 0006 0007 
Ibuprofen 400 400 400 400 400 400 400 
PEG 600 400 400 400 250 250 250 225 
Potassium hydroxide 40 50 50 50 50 50 50 
Water 55 50 100 50 100 80 60 
 
Evaluation of formulated capsules 
The liquid blend was prepared as per the developed formula. The 
batch of liquid was filled in gelatine shells of size ‘00' as a unit dose 
of 400 mg and labeled as Batch 0007. The evaluation of capsules 
included evaluation of the liquid fill material as well as the entire 
capsule. 
Evaluation of liquid fill material 
The liquid fill material of the final formulation was tested for various 
parameters of the solution. 
pH 
The pH of the fill material was measured using systronics pH Meter 
(Universal Enterprise, model no. UD 95) 
Viscosity 
The viscosity of fill material was measured using Brookfield 
viscometer (model DV-II, USA) equipped with spindle S27. The 
apparent viscosity was measured at room temperature at 50 
rotations per minutes (RPM) after five minutes. 
Density 
The density of fill material was measured using pycnometer. 
Infra-red spectrum 
The Infra Red (IR) spectrum of the formulation was obtained using 
FTIR instrument (ALPHA-PN10109/03, Bruker, Germany). IR 
spectrum of the pure drug was also obtained. The characteristic 
peaks of drug and formulation were compared. 
Differential scanning calorimetry (DSC) studies 
The physical status of ibuprofen in the solution was characterized 
using DSC thermogram analysis (STA 6000 simultaneous thermal 
analyzer, Perkin Elmer, Waltham, MA, USA). 5 gm of each (ibuprofen 
and ibuprofen solution) was placed in a standard aluminum pan and 
then purged with pure dry nitrogen gas at a flow rate of 10 ml/min 
prior to analysis. The temperature was increased at a rate of 10 
°C/minute and the heat flow was recorded from 30 °C to 300 °C.  
Evaluation of capsules 
The formulated ibuprofen capsules were evaluated as per general 
monograph of hard capsules in Indian Pharmacopoeia (IP) 2014. 
Uniformity of weight 
Variation in weight of each capsule will be proportional to variation 
in drug content. Thus, uniformity of weight was performed. An intact 
capsule was weighed. The contents were emptied. The shell was 
washed with alcohol and weighed. The difference in weight was 
used to determine the weight of content inside capsule. The same 
was repeated for 19 more capsules. Average weight and % RSD were 
calculated. 
Disintegration test 
6 capsules were evaluated for disintegration time using tablet 
disintegration apparatus. The capsules were inserted using discs in 
900 ml D. M. Water at a temperature of 37 °C. The time for its 
complete disintegration was noted. 
Drug content 
10 capsules were opened and contents were emptied. The content 
equivalent to a unit dose was taken in a 100 ml volumetric flask. To 
this 20 ml phosphate buffer pH 7.2 (prepared as per IP 2014) was 
added and sonicated. Volume was made up with phosphate buffer 
pH 7.2. The solution was further diluted appropriately. Absorbance 
were taken using UV-Visible spectrophotometer (Thermo Scientific 
Evolution 201) at 221 nm [32, 33].  
Dissolution studies 
Dissolution studies were conducted in triplicates in USP apparatus 2 
(Paddle apparatus). The dissolution media of 900 ml phosphate 
buffer (pH 7.2) was used as per IP 2014. The paddle rotation speed 
was set at 100 RPM and the temperature as 37 °C. The samples were 
introduced into the media using sinkers. 10 ml of dissolution sample 
were withdrawn at definite intervals. The dissolution batch was 
replaced with fresh media at specified time intervals. The 
withdrawn samples were filtered through 0.45 microns nylon filters. 
The samples were appropriately diluted with phosphate buffer (pH 
7.2). The absorbance of these diluted solutions was taken at 221 nm 
using UV-Visible spectrophotometer. 
The dissolution studies were performed on the formulated capsule 
(batch 0007 labeled as FI001), Advil®, a marketed softgel 
formulation and Brufen®
Statistical analysis 
, a marketed compressed tablet. The 
dissolution profiles of three different solid oral dosage forms were 
statistically compared.  
The dissolution profiles of different solid oral dosage forms were 
compared statistically using unpaired t-test (Graph Pad Prism, 
version 5.0.) [34]. 
Stability studies 
The samples for stability studies were stored in HDPE containers 
with canister. The samples were stored at room temperature as well 
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as at accelerated conditions at 40 °C and 75% Relative Humidity. 
The capsules were evaluated for stability at intervals of one month, 
two months and three months. 
RESULTS AND DISCUSSION 
Compatibility studies 
Compatibility studies between excipients and hard gelatin capsule 
shell revealed that the shell collapsed instantly when filled with 
water. The shell softened after 3 h in case of propylene glycol or 
glycerine. The shell showed cracking after 24 h when filled with PEG 
400, PEG 600 or Transcutol P. However, the shell showed no change 
in its appearance when filled with soyaoil, cremophor EL, 
Polysorbate 80, triacetin, transcutol P 20% or transcutol P 40%.  
Since the main objective is to formulate an aqueous solution, 
hydrophilic solvents were majorly considered for formulation 
development. Water, PEG 600 and PEG 400 were tested as solvents. 
However, compatibility results proved that the hydrophilic solvents 
cannot be used alone. They either lead to cracking or softening of 
capsule shells. Thus, Propylene Glycol and Glycerol were also tested 
for solubility as they can work as a co-solvent as well as plasticizer. 
Other components tested for compatibility majorly play a role in 
drug release and not solubility. Hence, they were not tested for 
solubility studies. 
Solubility studies 
The solubility of ibuprofen in every solvent under test was 
calculated and results were noted (fig. 1).
 
 
Fig. 1: Solubility of Ibuprofen in test solvents 
 
The solubility was found maximum in PEG 600. Compatibility results 
indicated that 100 % hydrophilic solvents cannot be used. Capsules 
being a unit dosage form entire dose should be incorporated in one 
capsule whose size is acceptable for human consumption. This led to 
trials of different methods for solubility enhancement.  
The common approaches for solubility enhancement are solid 
dispersion, particle size reduction, complexation, pH adjustment, 
salt formation to name a few. Ibuprofen procured was already 
micronized and so size reduction was not tried. Solid dispersion and 
complexation requires polymer in atleast 1:1 ratio. With 400 mg of 
dose, such methods would increase the target fill weight for a 
standard size of capsule for human consumption. On the basis of a 
literature search trials were focused on salt formation mechanism to 
increase solubility and achieve solution of unit dose in a consumable 
capsule. 
Formulation development 
Capsules are unit dosage forms and thus the entire dose of drug 
needs to be incorporated in one capsule. Size 00 can approximately 
accommodate 850 mg. It can vary to some extent depending on the 
density. The objective thus remains to solubilize 400 mg of 
ibuprofen to make final formulation of not more than 850 mg. 
As shown in table 1 formulation trails were designed using ionizing 
agent (Potassium hydroxide pellets) to enhance solubility. Batch 
0001 did not show complete solubility of drug probably due to 
insufficient alkaline environment for solubilization. In the next 
formulation trial batch 0002 concentration of potassium hydroxide 
pellets were increased to obtain complete solubility. But it lead to 
cracking within 24 h of filling and sealing. This was thought to be 
due to presence of unreacted hydroxyl ions or due to hygroscopic 
nature of ionizing agent. To overcome this, a humectant in the form 
of increased water content was explored. Thus in batch 0003 
concentration of water was increased. The capsules of this batch 
were also found to crack within 24 h. This indicated that the water 
added is not enough to counterbalance the hygroscopicity of 
formulation. This behavior is predominantly due to hygroscopic 
nature of either PEG 600 and/or ionizing agent. In Batch 0004 
concentration of PEG 600 was reduced keeping concentration of 
water enough to solubilize the drug. The capsules of this batch also 
showed cracking within 24 h of filling and sealing. Further increase 
in concentration of water was tried. Batch 0005 contained an 
increased concentration of water. This batch showed softening of 
capsule shells within 24 h of filling and sealing. This indicated that 
decreased concentration of PEG 600 with increase in concentration 
of water with optimum level can make formulation compatible with 
hard capsule shell. Batch 0006 contained decreased concentration of 
water as compared to batch 0005. The capsules of this batch also 
showed softening after 3 d of filling and sealing. As next trial the 
concentration of water was further reduced. Batch 0007 with 
reduced water was stable and compatible.  
Evaluation of formulated capsules 
Evaluation of liquid fill material 
The liquid of ibuprofen was tested for various parameters. The pH of 
the solution was found to be 6.69. The viscosity of the solution was 
441.9 cps and the density of the solution was 1.07 g/ml. 
Infra-red spectrum 
The IR spectrum of pure ibuprofen and the liquid formulation was 
recorded (fig. 2). Ibuprofen has its characteristic peak of carbonyl group 
near 1700 cm-1. The spectrum indicates that the characteristic peaks of 
pure drugs remain in the liquid. Thus, the drug is not degraded.
Jalundhwala et al. 




Fig. 2: IR spectrum of (a) pure ibuprofen and (b) formulation of ibuprofen 
 
 
Fig. 3: DSC thermogram of (a) ibuprofen and (b) formulation of ibuprofen 
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Differential scanning calorimetry (DSC) studies 
The results from DSC studies were recorded (fig. 3). 
The DSC studies measures melting points of drug and excipients. The 
melting point of drug changes with its crystalline nature. If the drug 
remains crystalline in formulation then no change in peak would be 
observed. The sharp peak in fig. above indicates melting point. The 
peak of pure ibuprofen is observed at 80.48 °C. Broad endotherm is 
seen which may be due to presence of water. The peak of pure 
ibuprofen is merged in a formulation that shows solubilization of drug. 
Evaluation of capsules 
The capsules were evaluated and found compliant as per 
specifications mentioned in general monograph of capsules in IP 
2014. The uniformity of weight of the batch of capsules was found to 
be 734.8 mg (±0.58). The disintegration time of these capsules was 
observed to be 4.45 min. The drug content was found to be 100.03%. 
Dissolution Studies 
Dissolution profile is graphically represented (fig. 4). 
 
 
Fig. 4: Dissolution profile in phosphate buffer pH 7.2 (mean±SD 
of n=3) 
 
The dissolution profile shows that softgels (Advil®) take longer time 
to release the drug. This is thought due to the longer disintegration 
time of softgels. The walls of softgels are thick and hence it may take 
a longer time to open and release the solubilized drug. The tablets 
are marketed as immediate release dosage forms and show a 
dissolution profile comparable with that for capsules of FI001 
(formulated capsules from trial batch 0007). The dissolution results 
of softgels and tablets were compared with formulated capsules 
statistically using unpaired t-test. The p values with Advil® as well as 
Brufen®
Stability studies 
 were found to be>0.05 and thus there was no significant 
difference between the dissolution of different dosage forms.  
The capsules were visually inspected for stability at timely intervals. 
The visual inspection included observation for any leakage or 
change in texture of capsule shell.  
The dissolution profiles obtained on intervals of 1 mo, 2 mo and 3 
mo were compared with that of initial dissolution profile. The 
samples were stored at different conditions and are graphically 
presented (fig. 5). 
 
 
Fig. 5: Dissolution profiles of stability samples (mean±SD of n=3) 
The dissolution profiles of stability samples showed that the product 
is stable over three months of test period under room temperature 
as well as accelerated conditions.  
CONCLUSION 
The developed capsule is a unit dose of liquid containing solubilized 
ibuprofen. The liquid is encapsulated in hard gelatine capsules with 
band sealing to avoid leakage. These capsules deliver drug directly 
in solubilized state in GIT. The hard capsules were found to deliver 
drug as an immediate delivery system. This increases bioavailability 
and decreases gastrointestinal disturbances caused by ibuprofen. 
The dissolution profile of these capsules showed higher release as 
compared to marketed softgels and tablets at the end of 5 min. 
These capsules may be suggested to have a more immediate effect as 
compared to other forms of immediate release. Manufacturing of 
these capsules is easier as there are less number of steps when 
compared to manufacturing of compressed tablets. The in-process 
quality control checks are less and variation is also minimal. Thus 
they have fewer rejections as compared to manufacturing of softgels. 
These are newer solid oral dosage forms with higher patient 
compliance and ease in manufacturing along with economic benefits. 
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